rs1263505

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000925538.1(ALG8):​c.*20A>G variant causes a splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.84 in 1,599,156 control chromosomes in the GnomAD database, including 566,505 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.86 ( 56459 hom., cov: 33)
Exomes 𝑓: 0.84 ( 510046 hom. )

Consequence

ALG8
ENST00000925538.1 splice_region

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.433

Publications

18 publications found
Variant links:
Genes affected
ALG8 (HGNC:23161): (ALG8 alpha-1,3-glucosyltransferase) This gene encodes a member of the ALG6/ALG8 glucosyltransferase family. The encoded protein catalyzes the addition of the second glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation of proteins. Mutations in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ih). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ALG8 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • ALG8-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • polycystic liver disease 3 with or without kidney cysts
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000925538.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 11-78100944-T-C is Benign according to our data. Variant chr11-78100944-T-C is described in ClinVar as Benign. ClinVar VariationId is 96088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.928 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000925538.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG8
NM_024079.5
MANE Select
c.*20A>G
downstream_gene
N/ANP_076984.2A0A024R5K5
ALG8
NM_001425224.1
c.*20A>G
downstream_gene
N/ANP_001412153.1
ALG8
NM_001425225.1
c.*20A>G
downstream_gene
N/ANP_001412154.1H0YDD3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG8
ENST00000925538.1
c.*20A>G
splice_region
Exon 10 of 10ENSP00000595597.1
ALG8
ENST00000925534.1
c.*20A>G
splice_region
Exon 4 of 4ENSP00000595593.1
ALG8
ENST00000853767.1
c.*20A>G
3_prime_UTR
Exon 11 of 11ENSP00000523826.1

Frequencies

GnomAD3 genomes
AF:
0.858
AC:
130567
AN:
152160
Hom.:
56404
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.936
Gnomad AMI
AF:
0.690
Gnomad AMR
AF:
0.759
Gnomad ASJ
AF:
0.872
Gnomad EAS
AF:
0.744
Gnomad SAS
AF:
0.826
Gnomad FIN
AF:
0.837
Gnomad MID
AF:
0.918
Gnomad NFE
AF:
0.848
Gnomad OTH
AF:
0.858
GnomAD2 exomes
AF:
0.823
AC:
206457
AN:
250820
AF XY:
0.828
show subpopulations
Gnomad AFR exome
AF:
0.937
Gnomad AMR exome
AF:
0.691
Gnomad ASJ exome
AF:
0.868
Gnomad EAS exome
AF:
0.758
Gnomad FIN exome
AF:
0.836
Gnomad NFE exome
AF:
0.848
Gnomad OTH exome
AF:
0.839
GnomAD4 exome
AF:
0.838
AC:
1212893
AN:
1446878
Hom.:
510046
Cov.:
28
AF XY:
0.838
AC XY:
604312
AN XY:
720880
show subpopulations
African (AFR)
AF:
0.941
AC:
31176
AN:
33146
American (AMR)
AF:
0.703
AC:
31408
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.870
AC:
22652
AN:
26024
East Asian (EAS)
AF:
0.695
AC:
27513
AN:
39604
South Asian (SAS)
AF:
0.828
AC:
71132
AN:
85932
European-Finnish (FIN)
AF:
0.837
AC:
44649
AN:
53330
Middle Eastern (MID)
AF:
0.909
AC:
5215
AN:
5734
European-Non Finnish (NFE)
AF:
0.845
AC:
928408
AN:
1098492
Other (OTH)
AF:
0.847
AC:
50740
AN:
59918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
10361
20723
31084
41446
51807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20714
41428
62142
82856
103570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.858
AC:
130681
AN:
152278
Hom.:
56459
Cov.:
33
AF XY:
0.854
AC XY:
63584
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.936
AC:
38931
AN:
41582
American (AMR)
AF:
0.759
AC:
11603
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.872
AC:
3025
AN:
3470
East Asian (EAS)
AF:
0.744
AC:
3848
AN:
5172
South Asian (SAS)
AF:
0.826
AC:
3987
AN:
4828
European-Finnish (FIN)
AF:
0.837
AC:
8883
AN:
10616
Middle Eastern (MID)
AF:
0.915
AC:
269
AN:
294
European-Non Finnish (NFE)
AF:
0.848
AC:
57690
AN:
68006
Other (OTH)
AF:
0.860
AC:
1817
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
949
1898
2848
3797
4746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.846
Hom.:
57052
Bravo
AF:
0.856
Asia WGS
AF:
0.802
AC:
2792
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
ALG8 congenital disorder of glycosylation (2)
-
-
2
not provided (2)
-
-
1
Congenital disorder of glycosylation (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
11
DANN
Benign
0.71
PhyloP100
0.43
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1263505;
hg19: chr11-77811990;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.